mRNA Length: 1,437 nucleotides
Concentration: 1.0 mg/mL
Buffer: 1 mM Sodium Citrate, pH 6.4
Agarose Gel Mobility; Pass
Concentration ± 6%; Pass
Ovalbumin (OVA) is a member of the serpin superfamily and the
predominant glycoprotein found in egg whites. It is a commonly used
antigen for immunization and biochemical studies and is an established
model allergen for airway hyper-responsiveness.
This mRNA is capped using CleanCap®, TriLink’s proprietary co-transcriptional capping method,
which results in the naturally occurring Cap 1 structure with high capping efficiency. It is polyadenylated and optimized for mammalian systems. It mimics a fully processed mature mRNA.
TriLink offers both unmodified and 5-methoxyuridine modified OVA mRNA. Exogenous unmodified mRNA activates
the innate immune system and production of cytokines, which will
influence the overall induced immune response. mRNA modified with
5-methoxyuridine reduces this effect.
Certificate(s) of Analysis
L-7610 is a replacement for L-6328.
Not for resale without express written permission. Not for use in humans. No license under any patent or patent pending is granted or implied by the purchase of any TriLink product. TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser’s sole responsibility.